XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid - In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021   37,991,529      
Beginning balance at Dec. 31, 2021 $ 157,438 $ 380 $ 425,769 $ (268,482) $ (229)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for exercise of stock options (in shares)   318,078      
Issuance of common stock for exercise of stock options 1,239 $ 3 1,236    
Vested restricted stock units converted to common stock (in shares)   263,605      
Vested restricted stock units converted to common shares 0        
Stock-based compensation 4,508   4,508    
Other comprehensive loss (169)       (169)
Net loss (6,649)     (6,649)  
Ending balance (in shares) at Jun. 30, 2022   38,573,212      
Ending balance at Jun. 30, 2022 156,367 $ 383 431,513 (275,131) (398)
Beginning balance (in shares) at Mar. 31, 2022   38,041,529      
Beginning balance at Mar. 31, 2022 152,594 $ 380 427,334 (274,842) (278)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for exercise of stock options (in shares)   268,854      
Issuance of common stock for exercise of stock options 1,019 $ 3 1,016    
Vested restricted stock units converted to common stock (in shares)   262,829      
Vested restricted stock units converted to common shares 0        
Stock-based compensation 3,163   3,163    
Other comprehensive loss (120)       (120)
Net loss (289)     (289)  
Ending balance (in shares) at Jun. 30, 2022   38,573,212      
Ending balance at Jun. 30, 2022 $ 156,367 $ 383 431,513 (275,131) (398)
Beginning balance (in shares) at Dec. 31, 2022 39,260,193 39,260,193      
Beginning balance at Dec. 31, 2022 $ 148,022 $ 393 439,005 (291,020) (356)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for exercise of stock options (in shares) 8,978 8,978      
Issuance of common stock for exercise of stock options $ 35   35    
Vested restricted stock units converted to common stock (in shares)   767,847      
Vested restricted stock units converted to common shares 0 $ 7 (7)    
Stock-based compensation 6,447   6,447    
Other comprehensive loss (77)       (77)
Net loss $ (16,453)     (16,453)  
Ending balance (in shares) at Jun. 30, 2023 40,037,018 40,037,018      
Ending balance at Jun. 30, 2023 $ 137,974 $ 400 445,480 (307,473) (433)
Beginning balance (in shares) at Mar. 31, 2023   39,509,346      
Beginning balance at Mar. 31, 2023 143,040 $ 395 442,170 (299,153) (372)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for exercise of stock options (in shares)   1,000      
Issuance of common stock for exercise of stock options 4 $ 0 4    
Vested restricted stock units converted to common stock (in shares)   526,672      
Vested restricted stock units converted to common shares 0 $ 5 (5)    
Stock-based compensation 3,311   3,311    
Other comprehensive loss (61)       (61)
Net loss $ (8,320)     (8,320)  
Ending balance (in shares) at Jun. 30, 2023 40,037,018 40,037,018      
Ending balance at Jun. 30, 2023 $ 137,974 $ 400 $ 445,480 $ (307,473) $ (433)